Metzler A, Tang H
Pathogens. 2024; 13(7).
PMID: 39057782
PMC: 11279898.
DOI: 10.3390/pathogens13070555.
Hsia J, Liu D, Haynes L, Cruz-Cosme R, Tang Q
Microorganisms. 2024; 12(4).
PMID: 38674592
PMC: 11051834.
DOI: 10.3390/microorganisms12040647.
Gao S, Shi R, Sun J, Tang Y, Zheng Z, Li J
iScience. 2022; 25(12):105481.
PMID: 36404916
PMC: 9668739.
DOI: 10.1016/j.isci.2022.105481.
Tan L, Komarasamy T, James W, Balasubramaniam V
Front Microbiol. 2022; 13:743147.
PMID: 35308394
PMC: 8931420.
DOI: 10.3389/fmicb.2022.743147.
Vue D, Tang Q
Zoonoses (Burlingt). 2021; 1(1).
PMID: 34957474
PMC: 8698461.
DOI: 10.15212/zoonoses-2021-0017.
The Epidermal Growth Factor Receptor Is a Relevant Host Factor in the Early Stages of The Zika Virus Life Cycle .
Sabino C, Bender D, Herrlein M, Hildt E
J Virol. 2021; 95(20):e0119521.
PMID: 34379506
PMC: 8475533.
DOI: 10.1128/JVI.01195-21.
Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses.
Carro S, Cherry S
Viruses. 2020; 13(1).
PMID: 33374822
PMC: 7824540.
DOI: 10.3390/v13010013.
The Multifaceted Roles of TAM Receptors during Viral Infection.
Wang Z, Wang P, An J
Virol Sin. 2020; 36(1):1-12.
PMID: 32720213
PMC: 7973326.
DOI: 10.1007/s12250-020-00264-9.
Integrin αvβ5 Internalizes Zika Virus during Neural Stem Cells Infection and Provides a Promising Target for Antiviral Therapy.
Wang S, Zhang Q, Tiwari S, Lichinchi G, Yau E, Hui H
Cell Rep. 2020; 30(4):969-983.e4.
PMID: 31956073
PMC: 7293422.
DOI: 10.1016/j.celrep.2019.11.020.
Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?.
Su K, Balasubramaniam V
Front Microbiol. 2019; 10:2715.
PMID: 31824472
PMC: 6879458.
DOI: 10.3389/fmicb.2019.02715.
A Novel Mechanism for Zika Virus Host-Cell Binding.
Rieder C, Rieder J, Sannajust S, Goode D, Geguchadze R, Relich R
Viruses. 2019; 11(12).
PMID: 31795144
PMC: 6949893.
DOI: 10.3390/v11121101.
Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection.
Sabino C, Basic M, Bender D, Elgner F, Himmelsbach K, Hildt E
Viruses. 2019; 11(6).
PMID: 31174294
PMC: 6630673.
DOI: 10.3390/v11060524.
Cell surface α2,3-linked sialic acid facilitates Zika virus internalization.
Tan C, Hor C, Kwek S, Tee H, Sam I, Goh E
Emerg Microbes Infect. 2019; 8(1):426-437.
PMID: 30898036
PMC: 6455136.
DOI: 10.1080/22221751.2019.1590130.
Toll-like receptor 3 regulates Zika virus infection and associated host inflammatory response in primary human astrocytes.
Ojha C, Rodriguez M, Muthu Karuppan M, Lapierre J, Kashanchi F, El-Hage N
PLoS One. 2019; 14(2):e0208543.
PMID: 30735502
PMC: 6368285.
DOI: 10.1371/journal.pone.0208543.
Zika Virus: Origins, Pathological Action, and Treatment Strategies.
Gorshkov K, Shiryaev S, Fertel S, Lin Y, Huang C, Pinto A
Front Microbiol. 2019; 9:3252.
PMID: 30666246
PMC: 6330993.
DOI: 10.3389/fmicb.2018.03252.
Complementary Mechanisms Potentially Involved in the Pathology of Zika Virus.
Ojha C, Rodriguez M, Lapierre J, Muthu Karuppan M, Branscome H, Kashanchi F
Front Immunol. 2018; 9:2340.
PMID: 30374352
PMC: 6196287.
DOI: 10.3389/fimmu.2018.02340.
Efficiencies and kinetics of infection in different cell types/lines by African and Asian strains of Zika virus.
Ramos da Silva S, Cheng F, Huang I, Jung J, Gao S
J Med Virol. 2018; 91(2):179-189.
PMID: 30192399
PMC: 6294704.
DOI: 10.1002/jmv.25306.
In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection.
Sarukhanyan E, Shityakov S, Dandekar T
ACS Omega. 2018; 3(5):5281-5290.
PMID: 30023915
PMC: 6044927.
DOI: 10.1021/acsomega.8b00223.
Zika virus crosses an in vitro human blood brain barrier model.
Alimonti J, Ribecco-Lutkiewicz M, Sodja C, Jezierski A, Stanimirovic D, Liu Q
Fluids Barriers CNS. 2018; 15(1):15.
PMID: 29759080
PMC: 5952854.
DOI: 10.1186/s12987-018-0100-y.
Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
Kudchodkar S, Choi H, Reuschel E, Esquivel R, Jin-Ah Kwon J, Jeong M
Microbes Infect. 2018; 20(11-12):676-684.
PMID: 29555345
PMC: 6593156.
DOI: 10.1016/j.micinf.2018.03.001.
